The Chronic Myeloid Leukaemia (CML) Support Group have grave concerns about the provisional recommendation contained in the Appraisal Consultation Document… read more
In a new draft guidance, published on May 6th 2011, NICE has not recommended dasatinib, nilotinib or high-dose imatinib for… read more
